0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Migraine in pediatric

Session 2: Migraine in pediatric & elderly patients

Tine Poole

General practitioner and headache specialist, Oslo Headache Centre, Norway

Download presentation

Previous

Migraine in elderly

Next

Misconceptions on migraine and treatments - social media, Google, etc.

You Might Also Like

Related Embedded Video Item Thumbnail The outlook of a tertiary treatment and research center
Related Embedded Video Item Thumbnail Treatment response as a biomarker
Related Embedded Video Item Thumbnail Biomarkers with focus on genetics
Related Embedded Video Item Thumbnail New EHF guideline on the use of MAb’s for migraine prevention
Related Embedded Video Item Thumbnail Combining preventative therapies

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct

Norway, Finland, Denmark: AJO-DK-NP-00128